Dottikon ES Holding (DESN) Stock Overview
Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
DESN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Dottikon ES Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 268.50 |
| 52 Week High | CHF 396.00 |
| 52 Week Low | CHF 263.50 |
| Beta | 1 |
| 1 Month Change | -7.73% |
| 3 Month Change | -22.96% |
| 1 Year Change | -13.80% |
| 3 Year Change | 13.05% |
| 5 Year Change | -7.41% |
| Change since IPO | 1,225.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| DESN | CH Pharmaceuticals | CH Market | |
|---|---|---|---|
| 7D | -2.4% | -0.06% | -0.7% |
| 1Y | -13.8% | 30.8% | 16.0% |
Return vs Industry: DESN underperformed the Swiss Pharmaceuticals industry which returned 30.8% over the past year.
Return vs Market: DESN underperformed the Swiss Market which returned 16% over the past year.
Price Volatility
| DESN volatility | |
|---|---|
| DESN Average Weekly Movement | 7.3% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in CH Market | 7.3% |
| 10% least volatile stocks in CH Market | 2.1% |
Stable Share Price: DESN's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: DESN's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1913 | 900 | Markus Blocher | dottikon.com |
Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also offers Dottisol, a non-GMO isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries.
Dottikon ES Holding AG Fundamentals Summary
| DESN fundamental statistics | |
|---|---|
| Market cap | CHF 3.71b |
| Earnings (TTM) | CHF 103.60m |
| Revenue (TTM) | CHF 439.92m |
Is DESN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DESN income statement (TTM) | |
|---|---|
| Revenue | CHF 439.92m |
| Cost of Revenue | CHF 170.49m |
| Gross Profit | CHF 269.43m |
| Other Expenses | CHF 165.83m |
| Earnings | CHF 103.60m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Nov 27, 2026
| Earnings per share (EPS) | 7.50 |
| Gross Margin | 61.25% |
| Net Profit Margin | 23.55% |
| Debt/Equity Ratio | 11.9% |
How did DESN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/13 03:53 |
| End of Day Share Price | 2026/07/10 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dottikon ES Holding AG is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tanya Hansalik | UBS Investment Bank |
| Daniel Jelovcan | Zürcher Kantonalbank |